Abstract
Objective
The choice between total gastrectomy (TG) and subtotal gastrectomy (STG) for early adenocarcinoma of the lower third of the stomach is still a matter of debate and controversy amongst surgeons. The aim of this study was to compare the surgical outcomes, quality of life (QoL), and local recurrence rates as well as other results of curative resection of early distal adenocarcinoma of the stomach using TG or STG performed in Iran.
Methods
Hospital records of 66 patients with early distal adenocarcinoma of stomach that underwent even total or subtotal gastrectomy with perigastric (D2) lymphadenectomy between October 2001 and February 2006 in Taleghani Hospital, Iran were reviewed retrospectively. Demographic data as well as clinicopathological factors including number of involved lymph nodes, tumor grading, depth of invation, tumor size, and tumor type were recorded. Post-operative outcomes including mortality and morbidity, tumor recurrence and quality of life were assessed. Univariate analyses using Fisher’s exact test, the Student t-test, and the Pearson χ2 test were used.
Results
Local recurrence of tumor was found in 8 (23%) TG group patients and in 19 (61%) patients of STG group. the Pearson χ2 test showed a significant higher recurrence rate in STG (P value=0.002, Relative Risk=2.68, Confidence Interval: 1.37–5.24).The mean time interval between gastrectomy and tumor recurrence was not different between TG and STG. (19.75±5.1 vs. 18.0±7.8 respectively; P value=0.507) Tumor size >5 cm (P value=0.004), diffuse type (P value=0.034), poor differentiation (P value=0.000) and serosal invasion (P value=0.012) were found to be significantly related to tumor recurrence in patients undergone gastrectomy. In none of the QoL measures a significant difference was found between TG and STG.
Conclusion
Our results show that subtotal and total gastrectomy methods with perigastric lymphadenectomy have a similar postoperative complication rate and surgical outcomes as well as patient’s QoL but STG was associated to a more than twofold increase in local recurrence risk.
Similar content being viewed by others
References
Ministry of Health and Medical Education. Death in Four Provinces of Iran[M]. 2000.
de Vries AC, Kuipers EJ. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies [J]. Helicobacter 2007; 12:22–31.
Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region [J]. J Dig Dis 2007; 8:179–185.
Matsuzaka M, Fukuda S, Takahashi I, et al. The decreasing burden of gastric cancer in Japan [J]. Tohoku J Exp Med 2007; 212:207–219.
Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence [J]. Gastric Cancer 2007; 10:75–83.
Scurtu R, Groza N, Otel O, et al. Quality of life in patients with esophagojejunal anastamosis after total gastrectomy for cancer [J]. Rom J Gastroenterol 2005; 14:367–372.
Liedman B. Symptoms after total gastrectomy on food intake, body composition, bone metabolism, and quality of life in gastric cancer patients—is reconstruction with a reservoir worthwhile [J]? Nutrition 1999; 15:677–682.
Fuchs CS, Mayer RJ. Gastric carcinoma [J]. N Engl J Med 1995; 333:32–41.
De Manzoni G, Verlato G, Roviello F, et al. Subtotal versus total gastrectomy for T3 adenocarcinoma of the antrum [J]. Gastric Cancer 2003; 6:237–242.
Roukos D, Schmidt-Mathiesen A, Encke A. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification [J]. Surg Oncol 1995; 4:323–332.
Cenitagoya GF, Bergh CK, Klinger-Roitman J. A prospective study of gastric cancer. ‘Real’ 5-year survival rates and mortality rates in a country with high incidence [J]. Dig Surg 1998; 15:317–322.
Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer [J]. Ann Surg 1994; 220:176–182.
Schlatter C. Uber Ernahrung und Verdauung nach vollstandiger Entfernung des Magens und Osophagojejunostomie beim Menschen, Brun’s Beitrage Klin Chir 1887; 19:757–776.
Lau MK, Le AT, El-Serag HB. Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival J]. Am J Gastroenterol 2006; 101:2485–2492.
Le A, Berger D, Lau M, et al. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States [J]. Ann Surg Oncol 2007; 14:2519–2527.
Smith JK, McPhee JT, Hill JS, et al. National outcomes after gastric resection for neoplasm [J]. Arch Surg 2007; 142:387–93.
Siewert JR, Böttcher K, Roder JD, et al. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group [J]. Br J Surg 1993; 80:1015–1018.
Roukos DH, Paraschou P, Lorenz M. Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery [J]. Ann Surg Oncol 2000; 7:719–726.
Piso P, Werner U, Lang H, et al. Proximal versus distal gastric carcinoma. What are the differences [J]? Ann Surg Oncol 2000; 7:520–525.
Hansson LE, Ekström AM, Bergström R, et al. Surgery for stomach cancer in a defined Swedish population: current practices and operative results. Swedish Gastric Cancer Study Group [J]. Eur J Surg 2000; 166:787–795.
McCulloch P, Ward J, Tekkis PP, ASCOT group of surgeons, British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study [J]. BMJ 2003; 327:1192–1197.
Adashek K, Sanger J, Longmire WP Jr. Cancer of the stomach: Review of consecutive ten year intervals [J]. Ann Surg 1979; 189:6–10.
White RR, Mackie JA, Fitts WT Jr. An analysis of twenty years’ experience with operations for carcinoma of the stomach [J]. Ann Surg 1975; 181:611–615.
Bittner R, Butters M, Ulrich M, et al. Total gastrectomy. Updated operative mortality and long-term survival with particular reference to patients older than 70 years of age [J]. Ann Surg 1996; 224:37–42.
Wu CW, Hsieh MC, Lo SS, et al. Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach [J]. J Am Coll Surg 1995; 181:26–32.
Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group [J]. Ann Surg 1997; 226: 613–620.
Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group [J]. Ann Surg 1999; 230:170–178.
Svedlund J, Sullivan M, Liedman B, et al. Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures [J]. World J Surg 1997; 21:422–433.
Davies J, Johnston D, Sue-Ling H, et al. Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life [J]. World J Surg 1998; 22:1048–1055.
Jentschura D, Winkler M, Strohmeier N, et al. Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection [J]. Hepatogastroenterology 1997; 44:1137–1142.
Braga M, Molinari M, Zuliani W, et al. Surgical treatment of gastric adenocarcinoma: impact on survival and quality of life. A prospective ten year study [J]. Hepatogastroenterology 1996; 43:187–193.
Korenaga D, Orita H, Okuyama T, et al. Quality of life after gastrectomy in patients with carcinoma of the stomach [J]. Br J Surg 1992; 79:248–250.
Larsson J, Akerlind I, Permerth J, et al. The relation between nutritional state and quality of life in surgical patients [J]. Eur J Surg 1994; 160:329–334.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moghimi, M., Marashi, S.A., Salehian, T. et al. Surgical outcomes and local recurrence following total or subtotal gastrectomy for early adenocarcinoma of antrum. Chin. J. Cancer Res. 20, 279–285 (2008). https://doi.org/10.1007/s11670-008-0279-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11670-008-0279-6